StockWatch
·
Pharmaceuticals
AGM/EGM4 Aug 2026, 02:33 pm

Morepen Labs 41st AGM on Sep 26; Approves Financials, Dividend Record Date

AI Summary

Morepen Laboratories Ltd announced its 41st Annual General Meeting (AGM) will be held on September 26, 2026. The Board of Directors, in a meeting on August 4, 2026, approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. A record date of September 19, 2026, was set for determining eligibility for the final dividend for FY26, subject to member approval at the AGM. The company also seeks member approval for extending the timeline to hive off its Medical Devices Business into a subsidiary and for the re-appointment of Mr. Sushil Suri as Chairman & Managing Director for three years from October 20, 2026.

Key Highlights

  • AGM scheduled for September 26, 2026.
  • Unaudited Q1 FY27 financial results approved.
  • Record date set for final dividend eligibility.
  • Seeking approval for Medical Devices Business divestment.
  • Re-appointment of CMD for a further three-year term.